cbd-for-seniors-neurological-health

The brain and central nervous system go through the aging process just like any other part of the human body. Neurodegeneration is the progressive loss of structural and functional neurons. Many neurological diseases are a direct result of this process. Once you are over the age of 65, you’re more likely to suffer from one neurological problem. 35.8% of seniors 85 years and older have moderate to severe memory impairment, making neurological health a priority among the senior community. The most common neurological disorders that afflict seniors include:

  • Dementia
  • Parkinson’s disease
  • Stroke
  • Alzheimer’s disease
  • Peripheral neuropathy and polyneuropathy
  • Epilepsy
  • Myasthenia Gravis

Seniors in assisted living communities are seven to 18 times more likely to use psychotropic drugs than middle-aged adults to manage neurological disorders. These pharmaceuticals are known to have serious side effects that seniors are more vulnerable to. When managing psychotropic drug use with other medications seniors may be taking for physical disorders, dedicated doctor guidance is vital. Since seniors are so much more vulnerable to these serious side effects, finding alternative treatments and ways to prevent neurological health disorders is pertinent.

 

Preclinical research has showcased CBD as a promising solution for neurological disorder prevention and for treating certain onset conditions.

 

CBD for Dementia

Dementia is a chronic neurological disorder that most commonly affects individuals aged 60 years and older. This incurable disease is characterized by the impairment of at least two major brain functions. The symptoms of dementia can include memory loss, limited social skills, and impaired judgment. Alzheimer’s disease is the root cause of 60% to 80% of reported dementia cases, while Huntington disease, frontotemporal dementia, Creutzfeldt-Jakob disease, vascular dementia, Korsakoff Syndrome, and mixed dementia account for the other cases. Cognition-enhancing medications and therapy are the only options available for managing symptoms, but some conditions are not reversible.

While preclinical research does show that CBD may help manage the behavioral symptoms of dementia, there currently is no evidence that it can help prevent the disease. Many studies are currently being conducted on CBD’s direct impact on neurodegenerative diseases.  

Resources: (Scientific studies)

Cannabis and dementia:

https://www.alzheimers.org.uk/about-dementia/treatments/alternative-therapies/cannabis-and-dementia

CBD Oil for Dementia: A Safer Alternative Medication for Senior Citizens:

https://www.marijuanabreak.com/cbd-oil-for-dementia

Cannabidiol: a promising drug for neurodegenerative disorders:

https://www.ncbi.nlm.nih.gov/pubmed/19228180

CBD for Parkinson’s Disease

Parkinson’s disease is a chronic central nervous system disorder that ultimately impacts motor function, often resulting in uncontrollable tremors, muscle stiffness, and numerous other debilitating symptoms. This incurable disorder is known as a senior disease and is usually diagnosed in people over the age of 60. Parkinson’s is actually the second most common age-related neurodegenerative disease after Alzheimer’s disease. A combination of dopamine promoters, antidepressants, cognition-enhancing medication, anti-tremor medications can be used to help manage the symptoms of Parkinson’s.

 

There are currently not enough scientific studies to make any definitive conclusions on CBD for Parkinson’s disease. Based on the preclinical research available, many findings do point to a potential effect of CBD improving the quality of life for patients suffering from Parkinson’s.

 

Resources: (Scientific studies)

Effects of cannabidiol in the treatment of patients with Parkinson’s disease:

https://www.ncbi.nlm.nih.gov/pubmed/25237116

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: importance of antioxidant and cannabinoid receptor-independent properties:

https://www.ncbi.nlm.nih.gov/pubmed/17196181

Cannabidiol for the treatment of psychosis in Parkinson’s disease:

https://www.ncbi.nlm.nih.gov/pubmed/18801821  

CBD for Strokes

Strokes are a very common medical emergency that occurs when there’s an interruption of blood supply to the brain resulting in damage that leads to issues with motor functions as well as paralysis or numbness of the face, leg, or arm. Early treatments may help minimize brain damage while other treatments are available for preventing additional strokes and limiting complications, but this condition cannot be cured. Strokes are the leading cause of adult disability in the United States and the rate of survival decreases with age. Seniors who have suffered from strokes can have a severely limited quality of life.

 

Recent preclinical research has focused on the neuroprotective effects of CBD and points to the potential therapeutic possibilities of CBD as a cerebroprotective agent. Further preclinical research has showcased CBD as a promising candidate for stroke prevention due to its endocannabinoid signaling. In addition to stroke prevention, CBD could be a viable treatment from defending permanent brain damage after a stroke has occurred.

 

Resources: (Scientific studies)

Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke:

https://www.ncbi.nlm.nih.gov/pubmed/28012949

CBD a Therapeutic Candidate for Stroke Prevention:

http://www.brainhealtheducation.org/cbd-a-therapeutic-candidate-for-stroke-prevention/

Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036658/

CBD for Alzheimer’s Disease

Alzheimer’s disease is a common chronic neurodegenerative disease that progressively destroys memory in addition to other vital mental functions. It accounts for 60% to 70% of all dementia cases and plagues seniors at a typical onset age of 65 years or older. There are currently no pharmaceutical treatments that can stop or reverse the progression of Alzheimer’s but cognitive-enhancing medication may temporarily improve symptoms.

 

Recent studies have shown that CBD reduces or removes the impact of inflammation, oxygen build up, and brain cell decline. The inflammatory response present in Alzheimer’s disease increases the negative symptoms and is caused when the brain’s immune cells fail to clear disorienting blockages. This inflammation which is the core cause of memory loss and other negative impacts on vital mental functions can be alleviated by CBD. More research is needed for a definitive answer, but preclinical studies point to CBD as a viable treatment for Alzheimer’s disease.  

 

Resources: (Scientific studies)

Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease:

https://www.ncbi.nlm.nih.gov/pubmed/26271310

Endocannabinoid signaling in Alzheimer’s disease:

https://www.ncbi.nlm.nih.gov/pubmed/24256258

 

 

CBD for Peripheral Neuropathy and Polyneuropathy

Peripheral neuropathy and polyneuropathy are characterized as weakness, numbness, and pain caused by nerve damage. Depression and anxiety are also a common symptom of neuropathy. Diabetes is the most common cause of neuropathy but these conditions can be a result of injuries, infections, and toxin exposure. These chronic conditions typically affect the hands and feet and have no curable treatments. Seniors are at a much higher risk for neuropathy, especially those who are diagnosed with diabetes. Antidepressants, opioids, and anti-seizure medications can offer temporary relief from symptoms.

 

Sativex, a pharmaceutical drug that has a combination of CBD and THC, has been approved by the FDA to control cancer-related neuropathy. Recent studies have proven that CBD can reduce muscle spasms and offer therapeutic benefits for those suffering from depression and anxiety. A lot of promising preclinical research shows CBD as a solution for peripheral neuropathy and polyneuropathy, making it a great alternative to opioids and muscle relaxers.

 

Resources: (Scientific studies)

Cannabinoids suppress inflammatory and neuropathic pain by targeting a3 glycine receptors:

https://www.ncbi.nlm.nih.gov/pubmed/22585736

Cannabinoids for neuropathic pain:

https://www.ncbi.nlm.nih.gov/pubmed/25160710

Meta-analysis of cannabis-based treatments for neuropathic and multiple sclerosis-related pain:

https://www.ncbi.nlm.nih.gov/pubmed/17257464

 

 

CBD for Epilepsy

Epilepsy is an incurable disease where nerve cell activity within the brain is disturbed which results in seizures. Epilepsy can be a result of a stroke, head injury, neurodegenerative disorders, alcoholism, or brain tumors, significantly putting seniors more at risk. Epilepsy is more likely to develop in seniors aged 55 years and older. It is often harder to recognize in seniors and may go unnoticed. Anticonvulsant medications are available to help control seizures in addition to nerve pain medication and sedatives.

 

CBD is a promising solution for epilepsy– many studies have shown its successful management in lowering seizures in epileptic patients. The first FDA-approved CBD pharmaceutical is for two rare forms of epilepsy Dravet syndrome and Lennox-Gastaut syndrome.  

 

Resources: (Scientific studies)

Cannabinoids for epilepsy:

https://www.ncbi.nlm.nih.gov/pubmed/22696383

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders:

https://www.ncbi.nlm.nih.gov/pubmed/24854329

Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy:

https://www.ncbi.nlm.nih.gov/pubmed/28367124

 

 

CBD for Myasthenia Gravis

Myasthenia gravis is typically a disease associated with younger individuals but recent increases of late-onset myasthenia gravis among patients ages 50 and older make this a significant concern among the senior community. Diagnosis and treatment options also highly differ among seniors. This incurable condition is caused by the breakdown in communication between the nerves and muscles resulting in weakness and chronic fatigue of muscles; difficulty swallowing; double vision; and droopy eyelids and mouth. Blood transfusion, muscle strengtheners, and steroids are used to temporarily help symptoms of myasthenia gravis.

 

More research is required, but preclinical studies show that CBD can improve muscle function and alleviate the chronic fatigue and pain associated with myasthenia gravis. The quality of life has been improved for those suffering from myasthenia gravis in recent patient studies. CBD offers a great alternative to the current treatment plans available.  

 

Resources: (Scientific studies and articles from the medical community)

Cannabinoids May Improve Muscle Function in Myasthenia Gravis, Mouse Study Suggests:

https://myastheniagravisnews.com/2018/04/03/cannabinoids-may-improve-muscle-function-myasthenia-gravis-mouse-model/

Patient with Myasthenia Gravis Markedly Improved with CBD, THC, and THC-Acid:

https://www.greenbridgemed.com/patient-with-myasthenia-gravis-markedly-improved-with-cbd-thc-and-thc-acid/

Myasthenia Gravis: Cannabidiol and THC-A:

https://unitedpatientsgroup.com/blog/2016/05/27/myasthenia-gravis-cannabidiol-thc


CBD Products for Seniors

Our CBD tincture can be used as a topical solution, perfect for acute arthritis relief alongside muscle soreness, general stiffness, and joint pain. This topical solution can be applied directly to any painful or stiff areas of the body, offering immediate relief. For more severe cases of arthritis and osteoporosis, we recommend utilizing our CBD tincture, CBD gummies, or CBD isolate. These applications offer higher dosage and relief for not only joint pain and disease, but also for neurological health, mental health, digestive and gastrointestinal health, and cardiovascular health. Our CBD tincture offers an optimal remedy for digestive and gastrointestinal health.

For more information regarding hemp-derived products for seniors, please give us a call!

Be Well

“Wellness extends beyond the exterior.”

THC-free products
This product is not for use by or sale to persons under the age of 18. The statements made regarding products listed on this site have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. We do also suggest that you conduct your own research.

Refund Policy
For best results, we recommend trying CBD for 2 weeks to feel maximum benefits, but if you are unsatisfied with this product in any way we'll give you your money back. Guaranteed! You may request a refund within 15 days of items receipt.

All of our products are completely THC-free and are legal in all 50 states.